Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1431.4000 24.20 (1.72%)
NSE Jul 10, 2026 15:31 PM
Volume: 189.6K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1431.40
1.72%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 120.06% in the last 6 Months
More from Rubicon Research Ltd.
Recommended
Five Interesting Stocks Today - July 10, 2026
The Baseline | 10 Jul 2026
Market closes higher, driven by easing oil prices and gains in realty and IT stocks
Trendlyne Marketwatch | 10 Jul 2026
Are active mutual funds worth the extra fees? We analysed over 200 funds to find out
The Baseline | 07 Jul 2026